BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34247191)

  • 21. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
    Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
    Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
    Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
    Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
    Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
    J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
    Tomida M; Heike T; Yokota T
    Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
    Ito Y; Yamamoto M; Mitsuma N; Li M; Hattori N; Sobue G
    Neurochem Res; 2001 Jan; 26(1):51-8. PubMed ID: 11358282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
    Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
    J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation.
    Du Q; Qian Y; Xue W
    Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129907. PubMed ID: 33845142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium.
    Aghajanova L; Stavreus-Evers A; Nikas Y; Hovatta O; Landgren BM
    Fertil Steril; 2003 Mar; 79 Suppl 1():808-14. PubMed ID: 12620495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis.
    Guan E; Liu H; Xu N
    Dig Dis Sci; 2022 Jun; 67(6):2244-2256. PubMed ID: 34050852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy.
    Clements ME; Holtslander L; Johnson JR; Johnson RW
    JBMR Plus; 2023 Mar; 7(3):e10694. PubMed ID: 36936362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of leukaemia inhibitory factor receptor subunits LIFR beta and gp130 in human oocytes and preimplantation embryos.
    van Eijk MJ; Mandelbaum J; Salat-Baroux J; Belaisch-Allart J; Plachot M; Junca AM; Mummery CL
    Mol Hum Reprod; 1996 May; 2(5):355-60. PubMed ID: 9238703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development.
    Zheng L; Yan B; Jin G; Han W; Wang H; Wang Z; Ma Y; Nian Y; Meng X; Jiang Z
    J Mol Histol; 2022 Apr; 53(2):173-186. PubMed ID: 35034206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor.
    Blanchard F; Tracy E; Smith J; Chattopadhyay S; Wang Y; Held WA; Baumann H
    Hepatology; 2003 Dec; 38(6):1516-28. PubMed ID: 14647063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
    Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
    Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.
    Ware CB; Nelson AM; Liggitt D
    Reprod Biol Endocrinol; 2003 May; 1():43. PubMed ID: 12823859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
    Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.